Trust the (cell manufacturing) process: Turning Research into ATMP in Flemingsberg!

Are you a practicing scientist from academia and/or industry, or simply interested in advanced therapies? We at the Flemingsberg Science Foundation warmly welcome you to the most important ATMP event of the spring!

When? March 21st
Where? Svartsjön room, Novum building, Campus Flemingsberg
Hälsovägen 7, 141 57 Huddinge

Stories of patients with long term durable responses to cell and gene therapies make headlines in the media and bring hope to patients in need of treatment options. However, getting new Advanced Therapy Medicinal Products (ATMPs) from the research lab to the reality of the patient bedside, relies not only on a robust and scalable cell manufacturing process, but also on successful navigation of the regulatory environment and an engaged and supportive ATMP community.

As stakeholders with a shared vision of creating momentum in accelerating access to ATMPs in the Nordics, Flemingsberg Science Foundation, Karolinska ATMP-centrum and Miltenyi Biotec Nordics are proud to host an educational seminar aimed at highlighting challenges and opportunities in getting new ATMPs from concept to clinic. Join Nordic cell therapy experts and enthusiasts in uniting towards bringing more ATMP options to more patients, more efficiently.

Welcome!

Speakers:
Johnny Högberg
Matti Sallberg
Pontus Blomberg
Stephan Mielke
Gustaf Ahlén
Di Yu
Stina Wickström
Nikola Vojnovic

Register here

Partners
Karolinska Universitetssjukhuset
Karolinska Institutet
Miltenyi Biotec
Elicera Therapeutics AB
ATMP Sweden

Published On: 8 February 2024

  • Martin Jönsson: “The time is ripe for a breakthrough in dementia treatment”

    Nearly 100,000 people in Sweden suffer from Alzheimer’s. Globally, about 30 million people are thought to have the disease. There is still no cure, but research is approaching a point where new drugs may become crucial. AlzeCure is one of the pharmaceutical companies that has made the most progress.

  • AlzeCure Pharma

    The stimulating environment with access to leading research in the area, and the positive climate on Campus Flemingsberg encourages exciting co-operation

  • Bactigard

    When we needed more space to establish an integrated facility for all our activities, including production, Flemingsberg was the natural choice

  • Biomedrex Genetics

    Thanks to great contacts, including Flemingsberg Science, we quickly got a place at Ana Futura in Flemingsberg.

  • Cellaviva: improving lives through stem cell technology

    Flemingsberg is a cluster for cell therapies that gives us proximity to partners, the clinical research and the trial clinic at Karolinska Hospital where many of the patients have received their treatment.